Literature DB >> 7642312

Tumor necrosis factor alpha acts as an autocrine second signal with gamma interferon to induce nitric oxide in group B streptococcus-treated macrophages.

K J Goodrum1, J Dierksheide, B J Yoder.   

Abstract

Nitric oxide production by mouse macrophages treated with group B streptococci and gamma interferon was inhibited by cytochalasin B or by antibody neutralization of macrophage-derived tumor necrosis factor alpha. Phagocytosis-induced tumor necrosis factor alpha is responsible for group B streptococcus-induced nitric oxide production in interferon-treated macrophages.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7642312      PMCID： PMC173516          DOI： 10.1128/iai.63.9.3715-3717.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.

Authors:  J A Langermans; M E Van der Hulst; P H Nibbering; P S Hiemstra; L Fransen; R Van Furth
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils.

Authors:  C L Smith; C J Baker; D C Anderson; M S Edwards
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

3.  Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent.

Authors:  K J Goodrum; L L McCormick; B Schneider
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

5.  Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci.

Authors:  P A Williams; J F Bohnsack; N H Augustine; W K Drummond; C E Rubens; H R Hill
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

6.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha.

Authors:  S B Corradin; Y Buchmüller-Rouiller; J Mauël
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

8.  Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.

Authors:  J C Drapier; J Wietzerbin; J B Hibbs
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

9.  Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.

Authors:  K P Beckerman; H W Rogers; J A Corbett; R D Schreiber; M L McDaniel; E R Unanue
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

10.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

Authors:  S H Chan; B Perussia; J W Gupta; M Kobayashi; M Pospísil; H A Young; S F Wolf; D Young; S C Clark; G Trinchieri
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307
View more
  9 in total

Review 1.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

2.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response.

Authors:  T Musso; R Badolato; D Ravarino; S Stornello; P Panzanelli; C Merlino; D Savoia; R Cavallo; A N Ponzi; M Zucca
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Involvement of the membrane form of tumour necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide.

Authors:  P Ancuta; H Fahmi; J F Pons; K Le Blay; R Chaby
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

5.  Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner.

Authors:  Ruby Fernandez-Boyanapalli; Kathleen A McPhillips; S Courtney Frasch; William J Janssen; Mary C Dinauer; David W H Riches; Peter M Henson; Aideen Byrne; Donna L Bratton
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

6.  CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2.

Authors:  M Segura; N Vadeboncoeur; M Gottschalk
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 7.  Induction and termination of inflammatory signaling in group B streptococcal sepsis.

Authors:  Julia Wennekamp; Philipp Henneke
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

8.  Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice.

Authors:  C A Derrico; K J Goodrum
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Immunomodulatory effects of the Tityus serrulatus venom on murine macrophage functions in vitro.

Authors:  Vera L Petricevich; Ivo Lebrun
Journal:  Mediators Inflamm       Date:  2005-02-24       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.